Akebia Therapeutics AKBA
NASDAQ AKBA
$0.87 -0.05 (-5.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Other Operating Expenses (2013 - 2026)

Updated

Akebia Therapeutics' Other Operating Expenses came in at $270,000 for Q2 2026, down 53.4% from $580,000 a year earlier and down 28.8% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Other Operating Expenses (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Akebia Therapeutics reported Other Operating Expenses of $1.81 million, up 87.1% year-over-year; for FY2023, it was -$524,000.

  • Going back by year, Other Operating Expenses was $1.59 million in FY2021 (+21.4%), $1.31 million in FY2020 (-1.5%) and $1.33 million in FY2019.
  • The Q2 2026 figure represents the lowest quarterly Other Operating Expenses since Q2 2023.
  • The fastest year-over-year change in Other Operating Expenses over five years came in Q3 2021 (growth of 314.3%), and the weakest in Q1 2023 (a decline of 62.1%).
  • Business Quant data shows AKBA's Other Operating Expenses at $379,000 (Q1 2026), $582,000 (Q4 2025) and $578,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Akebia Therapeutics 250.00 Mn -419.48 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 270,000.00
Mar 31, 2026 379,000.00
Dec 31, 2025 582,000.00
Sep 30, 2025 578,000.00
Jun 30, 2025 580,000.00
Mar 31, 2025 387,000.00
Mar 31, 2024 347,000.00
Jun 30, 2023 -524,000.00
Mar 31, 2023 170,000.00
Mar 31, 2022 449,000.00
Dec 31, 2021 1.03 Mn
Sep 30, 2021 870,000.00
Jun 30, 2021 894,000.00
Mar 31, 2021 695,000.00
Dec 31, 2020 327,000.00
Sep 30, 2020 210,000.00
Jun 30, 2020 544,000.00
Mar 31, 2020 676,000.00
Dec 31, 2019 469,000.00
Sep 30, 2019 329,000.00
API Access

Akebia Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AKBA&period=max&api_key=YOUR_API_KEY